|
Title
|
Published
|
Price
|
|
Feron Life Sciences-Company Report
By: Life Science Analytics (LSA)
Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the reports Accessing accurate, current and comprehensive content on private companies can be challenging and
|
more...
Search inside this report
|
9/30/2009
|
$750.00
|
|
Ferndale Laboratories, Inc.-Company Report
By: Life Science Analytics (LSA)
Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the reports Accessing accurate, current and comprehensive content on private companies can be challenging and
|
more...
Search inside this report
|
9/30/2009
|
$750.00
|
|
FDC Ltd.-Company Report
By: Life Science Analytics (LSA)
Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the reports Accessing accurate, current and comprehensive content on private companies can be challenging and
|
more...
Search inside this report
|
9/30/2009
|
$750.00
|
|
FCB-Pharmicell Co.,Ltd.-Company Report
By: Life Science Analytics (LSA)
Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the reports Accessing accurate, current and comprehensive content on private companies can be challenging and
|
more...
Search inside this report
|
9/30/2009
|
$750.00
|
|
FASgen, Inc.-Company Report
By: Life Science Analytics (LSA)
Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the reports Accessing accurate, current and comprehensive content on private companies can be challenging and
|
more...
Search inside this report
|
9/30/2009
|
$750.00
|
|
Faron Pharmaceuticals Ltd.-Company Report
By: Life Science Analytics (LSA)
Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the reports Accessing accurate, current and comprehensive content on private companies can be challenging and
|
more...
Search inside this report
|
9/30/2009
|
$750.00
|
|
Farmoquimica S/A-Company Report
By: Life Science Analytics (LSA)
Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the reports Accessing accurate, current and comprehensive content on private companies can be challenging and
|
more...
Search inside this report
|
9/30/2009
|
$750.00
|
|
Farmaprojects S.A.-Company Report
By: Life Science Analytics (LSA)
Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the reports Accessing accurate, current and comprehensive content on private companies can be challenging and
|
more...
Search inside this report
|
9/30/2009
|
$750.00
|
|
Farmapol Spolka z o.o.-Company Report
By: Life Science Analytics (LSA)
Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the reports Accessing accurate, current and comprehensive content on private companies can be challenging and
|
more...
Search inside this report
|
9/30/2009
|
$750.00
|
|
Farmacija d.o.o.-Company Report
By: Life Science Analytics (LSA)
Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the reports Accessing accurate, current and comprehensive content on private companies can be challenging and
|
more...
Search inside this report
|
9/30/2009
|
$750.00
|
|
FARAN LABORATORIES sa-Company Report
By: Life Science Analytics (LSA)
Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the reports Accessing accurate, current and comprehensive content on private companies can be challenging and
|
more...
Search inside this report
|
9/30/2009
|
$750.00
|
|
Falcon Pharmaceuticals, Ltd.-Company Report
By: Life Science Analytics (LSA)
Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the reports Accessing accurate, current and comprehensive content on private companies can be challenging and
|
more...
Search inside this report
|
9/30/2009
|
$750.00
|
|
FAES FARMA-Company Report
By: Life Science Analytics (LSA)
Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the reports Accessing accurate, current and comprehensive content on private companies can be challenging and
|
more...
Search inside this report
|
9/30/2009
|
$750.00
|
|
Fabre-Kramer Pharmaceuticals, Inc.-Company Report
By: Life Science Analytics (LSA)
Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the reports Accessing accurate, current and comprehensive content on private companies can be challenging and
|
more...
Search inside this report
|
9/30/2009
|
$750.00
|
|
EyeGene, Inc.-Company Report
By: Life Science Analytics (LSA)
Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the reports Accessing accurate, current and comprehensive content on private companies can be challenging and
|
more...
Search inside this report
|
9/30/2009
|
$750.00
|
|
EyeGate Pharmaceuticals, Inc-Company Report
By: Life Science Analytics (LSA)
Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the reports Accessing accurate, current and comprehensive content on private companies can be challenging and
|
more...
Search inside this report
|
9/30/2009
|
$750.00
|
|
Extrawell Pharmaceutical Holdings Limited-Company Report
By: Life Science Analytics (LSA)
Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the reports Accessing accurate, current and comprehensive content on private companies can be challenging and
|
more...
Search inside this report
|
9/30/2009
|
$750.00
|
|
Expression Genetics, Inc. (EGEN)-Company Report
By: Life Science Analytics (LSA)
Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the reports Accessing accurate, current and comprehensive content on private companies can be challenging and
|
more...
Search inside this report
|
9/30/2009
|
$750.00
|
|
ExonHit Therapeutics SA-Company Report
By: Life Science Analytics (LSA)
Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the reports Accessing accurate, current and comprehensive content on private companies can be challenging and
|
more...
Search inside this report
|
9/30/2009
|
$750.00
|
|
Evolva SA-Company Report
By: Life Science Analytics (LSA)
Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the reports Accessing accurate, current and comprehensive content on private companies can be challenging and
|
more...
Search inside this report
|
9/30/2009
|
$750.00
|
|
Everett Laboratories, Inc.-Company Report
By: Life Science Analytics (LSA)
Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the reports Accessing accurate, current and comprehensive content on private companies can be challenging and
|
more...
Search inside this report
|
9/30/2009
|
$750.00
|
|
Eusa Pharma (Europe) Ltd.-Company Report
By: Life Science Analytics (LSA)
Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the reports Accessing accurate, current and comprehensive content on private companies can be challenging and
|
more...
Search inside this report
|
9/30/2009
|
$750.00
|
|
Eurofarma-Company Report
By: Life Science Analytics (LSA)
Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the reports Accessing accurate, current and comprehensive content on private companies can be challenging and
|
more...
Search inside this report
|
9/30/2009
|
$750.00
|
|
Eurodrug Laboratories-Company Report
By: Life Science Analytics (LSA)
Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the reports Accessing accurate, current and comprehensive content on private companies can be challenging and
|
more...
Search inside this report
|
9/30/2009
|
$750.00
|
|
Euphoric Pharmaceuticals (P) Ltd-Company Report
By: Life Science Analytics (LSA)
Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the reports Accessing accurate, current and comprehensive content on private companies can be challenging and
|
more...
Search inside this report
|
9/30/2009
|
$750.00
|
|
Title
|
Published
|
Price
|